Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information
about the study results is available, it can also be found here.
> www.clinicaltrials.gov Once you are on the website, type “NCT03394144”
into the search box and click “Search”.
> www.AstraZenecaClinicalTrials.com Once you are on the website, type “D5660C00017”
into the search box, and click “Find a Study”.
Full Study Title: A Phase I, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics
and Anti-tumor Activity of AZD9150 monotherapy and AZD9150 in combination with durvalumab
in Japanese patients with Advanced Solid Malignancies
AstraZeneca Protocol Number: D5660C00017
National Clinical Trials number: NCT03394144
AstraZeneca K.K. sponsored this study and has its headquarters in Osaka, Japan.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions and find
medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_02_23
12 | Clinical Study Results